iBio, Inc. — Director's Dealing 2010

Sep 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBPM.OB)
CIK: 0001420720
Period of Report: 2010-08-16

Reporting Person: Chang Glenn (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-16	Stock Option (right to buy)	$1.73	A	30000	Acquired	2020-08-16	Common Stock (30000)	Direct

Footnotes

F1: The option vests in three equal annual installments beginning on July 1, 2010.